海豐(01308.HK)回升6.5%跑贏同業 獲匯豐再升價至33元
海豐國際(01308.HK)獲匯豐研究升價近18%至33元及重申「買入」評級,該股由紀錄高位三連吐至20天及10天線(25.75元及26.35元)之下後,今早跑贏航運股,最高見25.9元,現造25.35元,回升6.5%,成交402萬股。
海豐上月初公布,去年純利按年升60%至3.52億美元,每股盈利13.22美仙,末期股息按年增1.2倍至60港仙(4月29日除淨);總營收按年升8.5%至16.85億美元。業績曝光後,匯豐及大和隨即將海豐目標價分別升至28元及29元,以反映調高公司今明兩年盈測。
Follow us
Find us on
Facebook,
Twitter ,
Instagram, and
YouTube or frequent updates on all things investing.Have a financial topic you would like to discuss? Head over to the
uSMART Community to share your thoughts and insights about the market! Click the picture below to download and explore uSMART app!

Disclaimers
uSmart Securities Limited (“uSmart”) is based on its internal research and public third party information in preparation of this article. Although uSmart uses its best endeavours to ensure the content of this article is accurate, uSmart does not guarantee the accuracy, timeliness or completeness of the information of this article and is not responsible for any views/opinions/comments in this article. Opinions, forecasts and estimations reflect uSmart’s assessment as of the date of this article and are subject to change. uSmart has no obligation to notify you or anyone of any such changes. You must make independent analysis and judgment on any matters involved in this article. uSmart and any directors, officers, employees or agents of uSmart will not be liable for any loss or damage suffered by any person in reliance on any representation or omission in the content of this article. The content of the article is for reference only and does not constitute any offer, solicitation, recommendation, opinion or guarantee of any securities, virtual assets, financial products or instruments. Regulatory authorities may restrict the trading of virtual asset-related ETFs to only investors who meet specified requirements. Any calculations or images in the article are for illustrative purposes only.
Investment involves risks and the value and income from securities may rise or fall. Past performance is not indicative of future performance. Please carefully consider your personal risk tolerance, and consult independent professional advice if necessary.